EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2024-05-12 ms2000000050728541 来自北京

想问问投collection好不好

9 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2024-03-14 ms8000002033436461 来自江苏省

家人们 accept之后什么时候发确认proof邮件呀~

18 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2024-01-29 ms5000001463059972 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：鼻咽癌
经验分享：送外审2个月，因为找不到审稿人拒稿了

31 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2023-11-28 ms1000000297035092 来自吉林省

，京基百纳

13 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2023-06-02 肿瘤-Doctor Zhu 来自浙江省

审稿速度:6.0
偏重的研究方向：头颈部肿瘤
经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛

55 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2023-01-09 ms7000001893832347 来自湖北省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：meta分析;临床
经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住

43 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2022-10-15 肿瘤-Doctor Zhu

请问大家一般都会under review 多久呢，我中间时间变换了几次

40 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2022-06-27 ms5000001292778018

大家under review 都多久呢

44 0

[GetPortalCommentsPageByObjectIdResponse(id=1090195, encodeId=fa77109019568, content=长篇幅讨论是否展示作者对课题的思考？审稿人对MS印象好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204324, encodeId=ab8922043249e, content=想问问投collection好不好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60ea9297529, createdName=ms2000000050728541, createdTime=Sun May 12 22:39:07 CST 2024, time=2024-05-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193289, encodeId=97d9219328942, content=家人们 accept之后什么时候发确认proof邮件呀~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7fc08242198, createdName=ms8000002033436461, createdTime=Thu Mar 14 23:46:44 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184702, encodeId=29812184e02ec, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：鼻咽癌 经验分享：送外审2个月，因为找不到审稿人拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5258477773, createdName=ms5000001463059972, createdTime=Mon Jan 29 20:31:55 CST 2024, time=2024-01-29, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171591, encodeId=3b1621e159111, content=，京基百纳, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f47e9087278, createdName=ms1000000297035092, createdTime=Tue Nov 28 23:56:22 CST 2023, time=2023-11-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2140526, encodeId=aa0c21405269c, content=审稿速度:6.0 偏重的研究方向：头颈部肿瘤 经验分享：最近投了一篇文章 with editor了快2周了是因为国外编辑放假了吗有和我一样的朋友嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Fri Jun 02 19:10:11 CST 2023, time=2023-06-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2109582, encodeId=31da210958210, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：meta分析;临床 经验分享：2022年9月中旬在该杂志社投了一篇meta分析，11.1第一次小修，12.14左右第二次小修（非常小而且非常细致，审稿人直接建议我去掉哪个词，这种感觉），12.20就接收了，而且很友好地让选择是OA（2.5wRMB左右）还是传统订阅，虽然医院没有报销版面费的上限，但还是选择了非OA。由于感觉这个杂志蛮友好的，所以11.24提交了另外一篇meta，不过两篇文章的投稿者即通讯作者不一样；2023年1.6就直接发邮件说他们已经接收了？？？貌似只有一个审稿人简单夸了一下，就表示要接收了。整体而言我感觉比较容易？希望杂志的分数可以挺住, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39bb8189804, createdName=ms7000001893832347, createdTime=Mon Jan 09 22:09:28 CST 2023, time=2023-01-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2093931, encodeId=b483209393126, content=请问大家一般都会under review 多久呢，我中间时间变换了几次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f635482119, createdName=肿瘤-Doctor Zhu, createdTime=Sat Oct 15 15:10:27 CST 2022, time=2022-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228978, encodeId=adf012289e8bf, content=大家under review 都多久呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Mon Jun 27 16:27:23 CST 2022, time=2022-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226587, encodeId=369c122658e1b, content=under review下为什么时间还会变化？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e6c5389833, createdName=ms5000001292778018, createdTime=Wed Jun 15 13:43:39 CST 2022, time=2022-06-15, status=1, ipAttribution=)]

2022-06-15 ms5000001292778018

under review下为什么时间还会变化？

40 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务